FDA Seizes Tissue Valve Firm’s Entire Product Line, Citing Sterilization Issues
This article was originally published in The Gray Sheet
Executive Summary
U.S. marshals confiscated all devices manufactured by New Jersey-based Shelhigh in an April 17 seizure resulting from FDA concerns with product sterility
You may also be interested in...
FDA Follows Up Shelhigh Seizure With Formal Request For Recall
FDA is leaning on tissue product manufacturer Shelhigh to recall its entire product line after all inventory at its manufacturing facility was seized by federal marshals last month
FDA Follows Up Shelhigh Seizure With Formal Request For Recall
FDA is leaning on tissue product manufacturer Shelhigh to recall its entire product line after all inventory at its manufacturing facility was seized by federal marshals last month
FDA Announces Two More Medical Device Consent Decrees
FDA has already completed three consent decrees blocking sales of medical devices in 2007, with two surfacing last week. The agency has not obtained more than two device-related injunctions in any of the previous six years